Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-09T03:24:34.398Z Has data issue: false hasContentIssue false

Chapter 23 - Treating women with schizophrenia

from Section 5 - Psychotic disorders in women

Published online by Cambridge University Press:  05 March 2016

By
Shubulade Smith  and
Fiona Gaughran
Edited by
David J. Castle  and
Kathryn M. Abel
David J. Castle
Affiliation:
University of Melbourne
Kathryn M. Abel
Affiliation:
University of Manchester
Get access
Type
Chapter
Information
Comprehensive Women's Mental Health , pp. 307 - 319
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abel, K., Heathlie, H. F., Howard, L. M., & Webb, R. T. (2008). “Sex- and age-specific incidence of fractures in mental illness: a historical population-based cohort study.” J Clin Psychiatry, 69(9), 1398–1404.Google Scholar
Aichhorn, W., et al. (2006). “Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?” Drug Saf 29(7): 587–598.CrossRefGoogle ScholarPubMed
Alvares, A. P., et al. (1976). “Interactions between nutritional factors and drug biotransformations in man.” Proc Natl Acad Sci U S A, 73(7), 2501–2504.Google Scholar
Anthony, M., & Berg, M. J. (2002). “Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I.” J Womens Health Gend Based Med, 11(7), 601–615.CrossRefGoogle ScholarPubMed
Armani, F., et al. (2014). “Tamoxifen use for the management of mania: a review of current preclinical evidence.” Psychopharmacology (Berl) 231(4): 639–649.Google Scholar
Baggaley, M. (2008). “Sexual dysfunction in schizophrenia: focus on recent evidence.” Hum Psychopharmacol 23(3): 201–209.CrossRefGoogle ScholarPubMed
Bajaj, N., et al. (2010). “Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.” BMJ Case Rep 2010.CrossRefGoogle ScholarPubMed
Bauer, M., et al. (2014). “Role of lithium augmentation in the management of major depressive disorder.” CNS Drugs 28(4), 331–342.Google Scholar
Bellack, A. S., & Mueser, K. T. (1986). “A comprehensive treatment program for schizophrenia and chronic mental illness.” Community Ment Health J 22(3), 175–189.Google Scholar
Bennink, R., et al. (1998). “Comparison of total and compartmental gastric emptying and antral motility between healthy men and women.” Eur J Nucl Med 25(9): 1293–1299.Google Scholar
Bocchetta, A., et al. (2013). “Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study.” BMC Med 11: 33.Google Scholar
Bonoldi, I., et al. (2013). “Prevalence of self-reported childhood abuse in psychosis: a meta-analysis of retrospective studies.” Psychiatry Res 210(1): 8–15.Google Scholar
Brabban, A., et al. (2009). “Predictors of outcome in brief cognitive behavior therapy for schizophrenia.” Schizophr Bull 35(5): 859–864.CrossRefGoogle ScholarPubMed
Brunette, M. F. and Drake, R. E. (1997). “Gender differences in patients with schizophrenia and substance abuse.” Compr Psychiatry 38(2): 109–116.Google Scholar
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). “Psychiatric comorbidities and schizophrenia.” Schizophr Bull 35(2): 383–402.Google Scholar
Bundy, H., et al. (2011). “A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives.” Acta Psychiatr Scand 123(2): 98–106.Google Scholar
Bustillo, J., et al. (2001). “The psychosocial treatment of schizophrenia: an update.” Am J Psychiatry 158(2): 163–175.CrossRefGoogle ScholarPubMed
Chavez, C., et al. (2010). “The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study.” Brain Res 1321: 51–59.Google Scholar
Christodoulou, C. and Kalaitzi, C. (2005). “Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review.” J Psychopharmacol 19(3): 307–311.Google Scholar
Dickerson, F. B., et al. (2005). “The token economy for schizophrenia: review of the literature and recommendations for future research.” Schizophr Res 75(2–3), 405–416.Google Scholar
Di Forti, M., et al. (2014). “Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.” Schizophr Bull 40(6): 1509–1517.CrossRefGoogle ScholarPubMed
DiNitto, D. M., et al. (2002). “Gender differences in dually-diagnosed clients receiving chemical dependency treatment.” J Psychoactive Drugs 34(1): 105–117.Google Scholar
Donoghue, K., et al. (2014). “Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study.” Psychiatry Res 215(3):528–532. doi: 10.1016/j.psychres.2013.12.038. Epub 2014 Jan 4.CrossRefGoogle ScholarPubMed
Filia, S. L., et al. (2014). “Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention.” Psychiatry Res 215(3): 586–593.CrossRefGoogle Scholar
Fleeman, N., et al. (2011). “Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.” Pharmacogenomics J 11(1), 1–14.Google Scholar
Garety, P. A., et al. (2008). “Cognitive–behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial.” Br J Psychiatry 192(6): 412–423.Google Scholar
Gaughran, F., et al. (2013). “Improving physical health and reducing substance use in psychosis–randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial.” BMC Psychiatry 13: 263.Google Scholar
Giron, M., et al. (2010). “Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.” Psychol Med 40(1): 73–84.Google Scholar
Guada, J., et al. (2009). “The relationships among perceived criticism, family contact, and consumer clinical and psychosocial functioning for African-American consumers with schizophrenia.” Community Ment Health J 45(2): 106–116.Google Scholar
Harley, E. W., et al. (2010). “Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey.” Soc Psychiatry Psychiatr Epidemiol 45(7): 759–766.CrossRefGoogle ScholarPubMed
Hatfield, B., Huxley, P., Mohamad, H. (1997). “Social factors and compulsory detention of psychiatric patients in the UK. The role of the approved social worker in the 1983 Mental Health Act.” International Journal of Law and Psychiatry 20: 389–397.Google Scholar
Hillman, J. K., et al. (2014). “Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women without PCOS.” Fertil Steril 101(2): 530–535.CrossRefGoogle ScholarPubMed
Huxley, N. A., et al. (2000). “Psychosocial treatments in schizophrenia: a review of the past 20 years.” J Nerv Ment Dis 188(4): 187–201.Google Scholar
Inder, W. and Castle, D. (2011) “Antipsychotic-induced hyperprolactinaemia.” Australian and New Zealand Journal of Psychiatry 45: 830–837.Google Scholar
Jones, C., et al. (2012). “Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.” Cochrane Database Syst Rev 4, CD008712.Google Scholar
Kulkarni, J., et al. (2008). “Estrogen in severe mental illness: a potential new treatment approach.” Arch Gen Psychiatry 65(8): 955–960.Google Scholar
Kulkarni, J., et al. (2010). “Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.” Psychoneuroendocrinology 35(8): 1142–1147.CrossRefGoogle ScholarPubMed
Lally, J., Higaya, E., Nisar, Z., Bainbridge, E., Hallahan, B. (2013). “Prevalence study of head shop drug usage in mental health services.” The Psychiatrist 37:44–48, doi:10.1192/pb.bp.111.038315Google Scholar
Lane, H. Y., et al. (1999). “Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.” J Clin Psychiatry 60(1): 36–40.Google Scholar
Lear, S. A., et al. (2007). “Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT).” Am J Clin Nutr 86(2): 353–359.CrossRefGoogle ScholarPubMed
Lear, S. A., et al. (2009). “Ethnic variation in fat and lean body mass and the association with insulin resistance.” J Clin Endocrinol Metab 94(12): 4696–4702.Google Scholar
Leung, A. and Chue, P. (2000). “Sex differences in schizophrenia, a review of the literature.” Acta Psychiatr Scand Suppl 401: 3–38.CrossRefGoogle ScholarPubMed
Lorena, S. L., et al. (2004). “Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety.” J Clin Gastroenterol 38(3): 230–236.Google Scholar
Macdonald, S., et al. (2003). “Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study.” Br J Psychiatry 182: 50–56.Google Scholar
Martin-Reyes, M., et al. (2011). “Depressive symptoms evaluated by the Calgary Depression Scale for Schizophrenia (CDSS): genetic vulnerability and sex effects.” Psychiatry Res 189(1): 55–61.Google Scholar
Merkatz, R.,B., and Junod, S.W., (1994). “Historical background of changes in FDA policy on the study and evaluation of drugs in women.” Acad Med 69: 703–707.Google Scholar
McEvoy, J. P., et al. (2005). “Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.” Schizophr Res 80(1): 19–32.Google Scholar
Meibohm, B., et al. (2002). “How important are gender differences in pharmacokinetics?” Clin Pharmacokinet 41(5), 329–342.Google Scholar
Meyer, J. M., et al. (2005). “The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.” Schizophr Res 80(1): 9–18.Google Scholar
Mezey, G., et al. (2005). “Safety of women in mixed-sex and single-sex medium secure units: staff and patient perceptions.” Br J Psychiatry 187, 579–582.CrossRefGoogle ScholarPubMed
Micallef, J., et al. (2006). “Use of antidepressant drugs in schizophrenic patients with depression.” Encephale 32(2 Pt 1): 263–269.Google Scholar
Mortimer, A. M., et al. (2010). “Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.” Clin Schizophr Relat Psychoses 4(1): 49–55.Google Scholar
Nejtek, V. A., et al. (2012). “Race- and gender-related differences in clinical characteristics and quality of life among outpatients with psychotic disorders.” J Psychiatr Pract 18(5): 329–337.Google Scholar
Ozerdem, A., et al. (2014). “Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment.” Bipolar Disord 16(1): 72–82.Google Scholar
Perkins, R. & Rowland, L. (1991). “Sex differences in service usage in long-term psychiatric care are women adequately served?” Br J Psychiatry Suppl (10): 75–79.Google Scholar
Rosenbaum, B., et al. (2012). “Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome.” Psychiatry 75(4): 331–341.Google Scholar
Salokangas, R. K. (2004). “Gender and the use of neuroleptics in schizophrenia.” Schizophr Res 66(1): 41–49.CrossRefGoogle ScholarPubMed
Scandlyn, M. J., et al. (2008). “Sex-specific differences in CYP450 isoforms in humans.” Expert Opin Drug Metab Toxicol 4(4): 413–424.Google Scholar
Scott, J. E., & Dixon, L. B. (1995). “Psychological interventions for schizophrenia.” Schizophr Bull 21(4), 621–630.Google Scholar
Seeman, M. V. (1996). “The role of estrogen in schizophrenia.” J Psychiatry Neurosci 21(2), 123–127.Google Scholar
Seeman, M. V. (2012). “Menstrual exacerbation of schizophrenia symptoms.” Acta Psychiatr Scand 125(5): 363–371.Google Scholar
Seeman, M. V. and Ross, R. (2011). “Prescribing contraceptives for women with schizophrenia.” J Psychiatr Pract 17(4): 258–269.Google Scholar
Sensky, T., et al. (2000). “A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.” Arch Gen Psychiatry 57(2): 165–172.Google Scholar
Simoni-Wastila, L., et al. (2004). “A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders.” Clin Ther 26(2): 322–336.Google Scholar
Simoni-Wastila, L. and Strickler, G. (2004). “Risk factors associated with problem use of prescription drugs.” Am J Public Health 94(2): 266–268.Google Scholar
Smith, S. (2010). “Gender differences in antipsychotic prescribing.” Int Rev Psychiatry 22(5): 472–484.CrossRefGoogle ScholarPubMed
Smith, S. M., et al. (2002). “Sexual dysfunction in patients taking conventional antipsychotic medication.” Br J Psychiatry 181: 49–55.Google Scholar
Tang, C. S., et al. (2007a). “Gender differences in characteristics of Chinese treatment-seeking problem gamblers.” J Gambl Stud 23(2): 145–156.Google Scholar
Tang, Y. L., et al. (2007b). “Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.” Br J Clin Pharmacol 64(1): 49–56.Google Scholar
Teo, C., et al. (2013). “The role of ethnicity in treatment refractory schizophrenia.” Compr Psychiatry 54(2): 167–172.Google Scholar
Usall, J., et al. (2007). “Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.” Psychiatry Res 153(3): 225–231.Google Scholar
van Hulten, R., et al. (2003). “Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community.” Pharmacoepidemiol Drug Saf 12(1): 49–53.Google Scholar
van Os, J., et al. (1999). “Tardive dyskinesia in psychosis: are women really more at risk? UK700 Group.” Acta Psychiatr Scand 99(4): 288–293.Google Scholar
Wassink, T. H., et al. (1999). “Prevalence of depressive symptoms early in the course of schizophrenia.” Am J Psychiatry 156(2): 315–316.Google Scholar
Weich, S., et al. (2014). “Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study.” BMJ, 348, g1996.Google Scholar
Wieck, A. and Haddad, P. M. (2003). “Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.” Br J Psychiatry 182: 199–204.Google Scholar
Wild, R. A., et al. (2010). “Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.” J Clin Endocrinol Metab 95(5): 2038–2049.Google Scholar
Wolbold, R., et al. (2003). “Sex is a major determinant of CYP3A4 expression in human liver.” Hepatology 38(4), 978–988.Google Scholar
Wu, R. R., et al. (2012). “Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.” Am J Psychiatry 169(8): 813–821.Google Scholar
Wykes, T., et al. (2007). “Cognitive remediation therapy in schizophrenia: randomised controlled trial.” Br J Psychiatry 190, 421–427.Google Scholar
Wykes, T., et al. (2003). “Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.” Schizophr Res 61(2–3), 163–174.Google Scholar
Wykes, T., et al. (2011). “A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.” Am J Psychiatry 168(5): 472–485.Google Scholar
Xia, J., Merinder, L. B., & Belgamwar, M. R. (2011). “Psychoeducation for schizophrenia.” Cochrane Database Syst Rev(6): CD002831.Google Scholar
Xiang, Y. T., et al. (2012). “Adjunctive mood stabilizer and benzodiazepine use in older Asian patients with schizophrenia, 2001–2009.” Pharmacopsychiatry 45(6): 217–222.Google Scholar
Zarate, C. A. Jr., et al. (2007). “Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.” Bipolar Disord 9(6): 561–570.Google Scholar
Zhang, X. Y., et al. (2009). “Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.” Psychopharmacology (Berl) 205(4): 647–654.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×